Studies indicate that adult prevalence of ETD is estimated to be between 0.9% and 5.0%.1,2

The etiology of ETD may be linked to3:

  • Viral upper respiratory tract infection
  • Chronic sinusitis
  • Allergic rhinitis
  • Adenoid hypertrophy
  • Tobacco smoke
  • Reflux
  • Cleft palate
  • Radiation therapy
  • Reduced mastoid air cell system
  • Exposure to nitrous oxide

There is limited evidence to support current approaches to ETD treatments3

Different approaches to the treatment of ETD are available, but only one randomized controlled trial has been conducted. And in that study, nasal steroids showed no effect on ETD symptoms.

Other current ETD treatments:

  • Auto pressure equalization technique
  • Treatment with decongestants
  • Treatment with antihistamines
  • Surgical procedures including ventilation tubes, laser tuboplasty, and microdebrider tuboplasty

Why use the ACCLARENT AERA® Eustachian Tube Balloon Dilation System?

It  was  the  first  available  device  in  the  United  States  specifically  designed  to  dilate  the  Eustachian  tubes  for  patients  with  persistent  ETD  supported  by  a  prospective,  multicenter, randomized clinical trial.

See the Proven Results

Visit the Patient Site

References

  1. Browning GG, Catehouse S. The prevalence of middle ear disease in the adult British population. Clin Otolaryngol Allied Sci. 1992; 17(4):317-321.

  2. Ockermann T, Reineke U, Upile T, Ebmeyer J, Sudhoff HH. Balloon dilatation eustachian tuboplasty: a clinical study. Laryngoscope.2010;120(7):1411-1416.

  3. Randrup TS, Ovesen T. Balloon Eustachian tuboplasty: a systematic review. Otolaryngol Head Neck Surg. 2015;152(3):383-392.

109360-191202

Disclosures

Indications For Use

The ACCLARENT AERA® Eustachian Tube Balloon Dilation System is intended to dilate the Eustachian tube for treatment of persistent Eustachian tube dysfunction in adults ages 18 and older.

Important Safety Information

ACCLARENT AERA® Eustachian Tube Balloon Dilation System is intended for use by physicians who are trained on Acclarent Technology. Eustachian tube balloon dilation has associated risks, including tissue and mucosal trauma, infection, or possible carotid artery injury. Prior to use, it is important to read the Instructions for Use and to understand the contraindications, warnings, and precautions associated with these devices.

Caution: Federal (US) law restricts the sale, distribution or use of these devices to, by or on the order of a physician. Third party trademarks used herein are trademarks of their respective owners. This content is intended for audience within the US only.

Important information: Prior to use, refer to the instructions for use supplied with this device for indications, contraindications, side effects, warnings and precautions.

This site is published by Acclarent, Inc. which is solely responsible for its contents. It is intended for visitors from the United States.

© Acclarent, Inc. 2019. Last Updated on 1/24/2020